Temporal management patterns and outcomes of non-ST elevation acute coronary syndromes in patients with kidney dysfunction

European Heart Journal

Volumn 30, Issue 5, 2009, Pages 549-557

  Wong, Jorge A ^a,b   Goodman, Shaun G ^a,b   Yan, Raymond T ^a,b   Wald, Ron ^a   Bagnall, Alan J ^a,b   Welsh, Robert C ^c   Wong, Graham C ^d   Kornder, Jan ^e   Eagle, Kim A ^f   Steg, Philippe Gabriel ^g   Yan, Andrew T ^a,b  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b CANADIAN HEART RESEARCH CENTRE   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e SURREY MEMORIAL HOSPITAL   (Canada)

^f UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^g BICHAT HOSPITAL   (France)

Author keywords

Acute coronary syndrome; Coronary angiography; Kidney dysfunction; Outcome; Treatment

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; HEPARIN; THIENOPYRIDINE DERIVATIVE;

ACUTE CORONARY SYNDROME; ANGIOCARDIOGRAPHY; ARTICLE; CONSERVATIVE TREATMENT; GLOMERULUS FILTRATION RATE; HEART MUSCLE REVASCULARIZATION; HOSPITALIZATION; HUMAN; KIDNEY DYSFUNCTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; ST SEGMENT ELEVATION; SURVIVAL; TREATMENT OUTCOME; AGED; CLINICAL TRIAL; ELECTROCARDIOGRAPHY; FEMALE; KIDNEY DISEASE; MALE; MIDDLE AGED; MULTICENTER STUDY; RADIOGRAPHY; UTILIZATION REVIEW;

ACUTE CORONARY SYNDROME; AGED; AGED, 80 AND OVER; CORONARY ANGIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; GLOMERULAR FILTRATION RATE; HOSPITALIZATION; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 63349084335     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehp014     Document Type: Article

References (35)

1. Al Suwaidi J, Reddan DN, Williams K, Pieper KS, Harrington RA, Califf RM, Granger CB, Ohman EM, Holmes DR. Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation 2002; 106:974-980.
2. Anavekar NS, McMurray JJV, Velazquez EJ, Solomon SD, Kober L, Rouleau J, White HD, Nordlander R, Maggioni A, Dickstein K, Zelenkofske S, Leimberger JD, Califf RM, Pfeffer MA. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004;351: 1285-1295.
3. Santopinto JJ, Fox KAA, Goldberg RJ, Budaj A, Pinero G, Avezum A, Gulba D, Esteban J. Gore JM. Johnson J. Gurfinkel EP. Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: findings from the global registry of acute coronary events (GRACE). Heart 2003;89:1003-1008.
4. Shlipak MG, Heidenreich PA, Noguchi H, Chertow GM. Browner WS, McClellan MB. Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med 2002;137:555-562.
5. Gibson CM, Dumaine RL, Gelfand EV, Murphy SA, Morrow DA, Wiviott SD, Giugliano RP, Cannon CP, Antman EM. Braunwald E. Association of glomerular filtration rate on presentation with subsequent mortality in non-ST-segment elevation acute coronary syndrome; observations in 13307 patients in five TIMI trials. Eur Heart J 2004;25:1998-2005.
6. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L Spinosa DJ, Wilson PW. Kidney disease as a risk factor for development of cardiovascular disease-a statement from the American Heart Association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation 2003;108:2154-2169.
7. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, Jones RH, Kereiakes D, Kupersmith J, Levin TN, Pepine CJ, Schaeffer JW, Smith EE, Steward DE, Theroux P, Gibbons RJ, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Smith SC. ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-2002: summary article-a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). Circulation 2002;106:1893-1900.
8. Cannon CP, Weintraub WS, Demopoulos LA, Vicari R, Frey MJ, Lakkis N, Neumann FJ, Robertson DH, DeLucca PT, DiBattiste PM, Gibson CM, Braunwald E. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein llb/llla inhibitor tiroflban. N Engl J Med 2001;344:1879-1887.
9. Fox KAA, Poole-Wilson P, Clayton TC, Henderson RA, Shaw TRD, Wheatley DJ, Knight R, Pocock SJ. 5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial. Lancet 2005;366:914-920.
10. Wallentin L Swahn E, Kontny F, Husted S, Lagerqvist B, Stahle E, Nielsen JD, Dellborg M, Geiran O, Grande P, Hulting J, Kyst-Madsen J, Nordrehaug JE, Naslund U, Pilegaard H, Rollag A, Nielsen TT, Saetre H, Siegbahn A, Ohlin H, Arbeus M, Bylund H, Ekstrom L Eriksson P, Holmgren A, Kellerth T, Lindblom D, Lindvall B, Nordrehaug J, Radegran K, Sjogren I, Stenport G, Stahl E, Svane B, Svedjeholm R, Toftegaard-Nielsen T, Hassan SY, Persson S, Jacobsson KA, Thygesen K, von der Lippe G, Julian D, Bertrand M, Wedel H, Andren B, Diderholm E, Frostfeldt G, Jernberg T, Abrahamsson P, Lindahl B, Venge P, Janzon M, Logander E, Svensson E, Lindstrom G, Alsjo G, Gulin M, Setterberg G. Wikstrom L, M-Andersen I, Seim T. Invasive compared with noninvasive treatment in unstable coronary-artery disease: FRISC ll prospective randomised multicentre study. Lancet 1999;354:708-715.
11. Coca SG, Krumholz HM, Garg AX, Parikh CR. Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease. JAMA 2006; 296:1377-1384.
12. Beanie JN, Soman SS, Sandberg KR, Yee J, Borzak S, Garg M, McCullough PA. Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction. Am J Kidney Dis 2001;37:1191-1200.
13. McCullough PA. Why is chronic kidney disease the 'Spoiler' for cardiovascular outcomes? J Am Coll Cardiol 2003;41:725-728.
14. McCullough PA. Sandberg KR, Borzak S, Hudson MP, Garg M, Manley HJ. Benefits of aspirin and beta-blockade after myocardial infarction in patients with chronic kidney disease. Am Heart J 2002;144:226-232.
15. Wright RS, Reeder GS, Herzog CA, Albright RC, Williams BA, Dvorak DL Miller WL Murphy JG, Kopecky SL, Jaffe AS. Acute myocardial infarction and renal dysfunction: A high-risk combination. Ann Intern Med 2002;137:563-570.
16. Yan AT, Yan RT, Tan M, Constance C, Lauzon C, Zaltzman J, Wald R, Fitchett D, Langer A, Goodman SG. Treatment and one-year outcome of patients with renal dysfunction across the broad spectrum of acute coronary syndromes. Can J Cardiol 2006;22:115-120.
17. Granger CB. Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon CP, Van de Werf F, Avezum A, Goodman SG, Flather MD. Fox KAA. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med 2003; 163:2345-2353.
18. Yan AT, Tan M, Fitchett D, Chow CM, Fowlis RA, McAvinue TG, Roe MT, Peterson ED, Tu JV, Langer A, Goodman SG. One year outcome of patients after acute coronary syndrome's (from the Canadian acute coronary syndromes registry). Am J Cardiol 2004;94:25-29.
19. Stevens LA, Coresh J, Greene T, Levey AS. Medical progress-assessing kidney function-measured and estimated glomerular filtration rate. N Engl J Med 2006;354:2473-2483.
20. Bhatt DL Roe MT, Peterson ED, Li Y, Chen AY, Harrington RA, Greenbaum AB, Berger PB, Cannon CP, Cohen DJ, Gibson CM, Saucedo JF, Kleiman NS, Hochman JS, Boden WE, Brindis RG, Peacock WF, Smith SC, Pollack CV, Gibier WB, Ohman EM. Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromesresults from the CRUSADE quality improvement initiative. JAMA 2004;292: 2096-2104.
21. Eagle KA, Lim MJ, Dabbous OH, Pieper KS, Goldberg RJ, Van de Werf F, Goodman SG, Granger CB, Steg PG, Gore JM, Budaj A, Avezum A, Flather MD, Fox KA. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. JAMA 2004;291:2727-2733.
22. D'Agostino RB. Propensity scores in cardiovascular research. Circulation 2007;115: 2340-2343.
23. Freeman RV, Mehta RH, Al Badr W, Cooper JV, Kline-Rogers E, Eagle KA. Influence of concurrent renal dysfunction on outcomes of patients with acute coronary syndromes and implications of the use of glycoprotein llb/llla inhibitors. J Am Coll Cardiol 2003;41:718-724.
24. Januzzi JL, Cannon CP, DiBattiste PM, Murphy S, Weintraub W, Braunwald E. Effects of renal insufficiency on early invasive management in patients with acute coronary syndromes (The TACTICS-TIMI 18 trial). Am J Cardiol 2002;90: 1246-1249.
25. Johnston N, Jernberg T, Lagerqvist B, Wallentin L. Early invasive treatment benefits patients with renal dysfunction in unstable coronary artery disease. Am Heart J 2006;152:1052-1058.
26. Keeley EC, Kadakia R, Soman S, Borzak S, McCullough PA. Analysis of long-term survival after revascularization in patients with chronic kidney disease presenting with acute coronary syndromes. Am J Cardiol 2003;92:509-514.
27. Bavry AA, Kumbhani DJ, Rassi AN, Bhatt DL, Askari AT. Benefit of early invasive therapy in acute coronary syndromes: a meta-analysis of ontemporary randomized clinical trials. J Am Coll Cardiol 2006;48:1319-1325.
28. Mehta SR, Cannon CP, Fox KAA, Wallentin L, Boden WE, Spacek R, Widimsky P, McCullough PA, Hunt D, Braunwald E, Yusuf S. Routine vs selective invasive strategies in patients with acute coronary syndromes-a collaborative meta-analysis of randomized trials. JAMA 2005;293:2908-2917.
29. Yan AT, Yan RT, Tan M, Eagle KA, Granger CB, Dabbous OH, Fitchett D, Grima E, Langer A, Goodman SG. In-hospital revascularization and one-year outcome of acute coronary syndrome patients stratified by the GRACE risk score. Am J Cardiol 2005;96:913-916.
30. Foley RN; Murray AM, Li SL, Herzog CA, McBean AM, Eggers PW, Collins AJ. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States medicare population, 1998 to 1999. J Am Soc Nephrol 2005;16:489-495.
31. Fox KA, Goodman SG, Anderson FA, Granger CB, Moscucci M, Flather MD, Spencer F, Budaj A, Dabbous OH, Gore JM. From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2003;24:1414-1424.
32. Lee CH, Tan M, Yan AT, Yan RT, Fitchett D, Grima EA, Langer A, Goodman SG. Use of cardiac catheterization for non-ST-segment elevation acute coronary syndromes according to initial risk: reasons why physicians choose not to refer their patients. Arch Intern Med 2008;168:291-296.
33. Yan AT, Yan RT, Tan M. Fung A, Cohen EA, Fitchett DH, Langer A, Goodman SG. Management patterns in relation to risk stratification among patients with non-ST elevation acute coronary syndromes. Arch Intern Med 2007;167:1009-1016.
34. Yan AT, Yan RT, Tan M, Casanova A, Labinaz M, Sridhar K, Fitchett DH, Langer A, Goodman SG. Risk scores for risk stratification in acute coronary syndromes: useful but simpler is not necessarily better. Eur Heart J 2007;28:1072-1078.
35. Manfrini O, Bugiardini R. Barriers to clinical risk scores adoption. Eur Heart J 2007; 28:1045-1046.